# Pharmacokinetic Interaction Between AZD3480 and Donepezil

> **NCT00713765** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 33 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** AZD3480
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00713765
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Ended prematurely - The trial never commenced.
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713765, "Pharmacokinetic Interaction Between AZD3480 and Donepezil". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00713765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*